Ian V.

Ian V. serves as the Chief Financial Officer at Alcresta Therapeutics since October 2025 and has been the Principal at IJV Consulting since April 2013, specializing in finance, accounting, international reporting, strategic planning, and due diligence for various clients, including family offices and professional services firms. Previously, Ian held CFO positions at several companies, including Channel Medsystems, Tepha, Inc., and CSA Medical, significantly contributing to the development and commercialization of medical innovations. With extensive experience in financial leadership within the healthcare sector, Ian also held key roles at Covidien, Tissue Science Laboratories, CADImplant, and EDAP TMS, demonstrating expertise in financial management, strategic investments, and compliance reporting. Ian V. earned a Bachelor of Science in Business Administration from Norwich University in 1996.